Terms: = Liver cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
12 results:
1. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus.
Zhang S; He L; Bo C; Yang S; An Y; Li N; Zhao Y; Zhao L; Ma W; Zheng Z
Radiat Oncol; 2021 Aug; 16(1):149. PubMed ID: 34391452
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of AXIN1 and axin2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
[TBL] [Abstract] [Full Text] [Related]
4. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
[TBL] [Abstract] [Full Text] [Related]
5. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
[TBL] [Abstract] [Full Text] [Related]
6. Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease.
Lin WC; Chang CW; Chang CW; Wang TE; Chen MJ; Wang HY
Medicine (Baltimore); 2019 Aug; 98(35):e17007. PubMed ID: 31464957
[TBL] [Abstract] [Full Text] [Related]
7. Psoralen induced cell cycle arrest by modulating Wnt/β-catenin pathway in breast cancer cells.
Wang X; Xu C; Hua Y; Cheng K; Zhang Y; Liu J; Han Y; Liu S; Zhang G; Xu S; Yang Z
Sci Rep; 2018 Sep; 8(1):14001. PubMed ID: 30228287
[TBL] [Abstract] [Full Text] [Related]
8. Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway.
Chang FZ; Wang Q; Zhang Q; Chang LL; Li W
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4500-4508. PubMed ID: 30058686
[TBL] [Abstract] [Full Text] [Related]
9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
10. Autophagy-dependent generation of axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
Li J; Hu SB; Wang LY; Zhang X; Zhou X; Yang B; Li JH; Xiong J; Liu N; Li Y; Wu YZ; Zheng QC
Oncogene; 2017 Nov; 36(48):6725-6737. PubMed ID: 28783177
[TBL] [Abstract] [Full Text] [Related]
11. Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span.
Amer M; Elhefnawi M; El-Ahwany E; Awad AF; Gawad NA; Zada S; Tawab FM
Tumour Biol; 2014 Nov; 35(11):11301-9. PubMed ID: 25119594
[TBL] [Abstract] [Full Text] [Related]
12. Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells.
Gwak J; Lee JH; Chung YH; Song GY; Oh S
PLoS One; 2012; 7(10):e46697. PubMed ID: 23071615
[TBL] [Abstract] [Full Text] [Related]
